Open-label Study With Bosentan in Interstitial Lung Disease

NCT00319033 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Interstitial Lung Disease
Scleroderma

Interventions

DRUG: bosentan

Sponsor

Actelion